Corpus Engine Towards a reproducible .science file.
← All .science files

pmid:34235004

The clinicopathological significance and predictive value for immunotherapy of programmed death ligand-1 expression in Epstein-Barr virus-associated gastric cancer.

Xiao-Li Wei · Qian-Wen Liu · Fu-Rong Liu · Sha-Sha Yuan · Xiao-Fen Li · Jia-Ning Li · An-Li Yang · Yi-Hong Ling

Oncoimmunology · 2021 doi:10.1080/2162402X.2021.1938381

Paper

complete

Experiment

complete

Data

partial

Analysis

absent

Execution

absent

Execution evidence has not yet been added to this .science file. Explore its methods, data and open questions to plan the next step.
Record details sci_version · id · kind · revision · content_hash · schema · created_at · updated_at · generator
id
pmid:34235004
kind
science-record
content_hash
sha256:ec040b8e0f0a3f5f5374c14024658c9f08b9a7d1abd5d1b400285d6822505c76
schema
https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json
created_at
2026-11-01T15:41:42Z
updated_at
2026-11-01T18:56:02Z
generator object · 2 fields
name
corpus-assay-engine
run_id
reading-sci-2026-11-01
paper object · 10 fields
state
complete
title
The clinicopathological significance and predictive value for immunotherapy of programmed death ligand-1 expression in Epstein-Barr virus-associated gastric cancer.
doi
10.1080/2162402X.2021.1938381
pmid
34235004
authors array · 8 items
[0]
Xiao-Li Wei
[1]
Qian-Wen Liu
[2]
Fu-Rong Liu
[3]
Sha-Sha Yuan
[4]
Xiao-Fen Li
[5]
Jia-Ning Li
[6]
An-Li Yang
[7]
Yi-Hong Ling
journal
Oncoimmunology
year
2021
abstract
The effect of anti-programmed cell death 1 (PD-1) antibody in Epstein-Barr virus-associated gastric cancer (EBVaGC) was debatable, and no predictive biomarkers for efficacy have been reported. Public reports on anti-PD-1 antibody monotherapy-treated EBVaGC with available programmed death ligand-1 (PD-L1) expression status were summarized and analyzed. Relevance with clinicopathologic characteristics of PD-L1 expression by immunohistochemistry was analyzed in 159 patients diagnosed with EBVaGC. Relevance with genomic transcriptome and mutation profile of PD-L1 status in EBVaGC was assessed with three datasets, the cancer genome atlas (TCGA), Gene Expression Omnibus (GEO) GSE51575, and GSE62254. Based on the data from 8 reports, patients with positive PD-L1 expression (n = 30) had significantly superior objective response rate (ORR) than patients with negative PD-L1 expression (n = 9) (63.3% vs. 0%, P = .001) in EBVaGC receiving anti-PD-1 antibody monotherapy. PD-L1 positivity was associated with less aggressive clinicopathological characteristics and was an independent predictor for a longer disease-free survival (hazard ratio [HR] and 95% CI: 0.45 [0.22-0.92], P = .03) and overall survival (HR and 95% CI: 0.17 [0.06-0.43], P < .001). Analysis of public EBVaGC transcriptome and mutation datasets revealed enhanced immune-related signal pathways in PD-L1high EBVaGC and distinct mutation patterns in PD-L1low EBVaGC. PD-L1 positivity indicates a subtype of EBVaGC with 'hot' immune microenvironment, lower aggressiveness, better prognosis, and higher sensitivity to anti-PD-1 immunotherapy.
claims array · 1 item
[0] object · 6 fields
id
claim-data-access
statement
Data are available on reasonable request. All data generated that are relevant to the results presented in this article are included in this article. Other data that were not relevant for the results presented here are available from the corresponding author Dr. Ling on reasonable request.
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:34235004
locator
sections[20] "Data sharing statement" paragraph 2
quote
Data are available on reasonable request. All data generated that are relevant to the results presented in this article are included in this article. Other data that were not relevant for the results presented here are available from the corresponding author Dr. Ling on reasonable request.
state
complete
gaps array · 0 items
experiment object · 8 fields
state
complete
objective
null
steps array · 3 items
[0] object · 13 fields
id
read_published_estimate
order
1
name
Read the published estimate from the source
kind
other
state
complete
blocked_on
null
description
The claim, method and evidence span published with the source article.
parameters object · 0 fields
inputs array · 1 item
[0]
source:pmid:34235004
outputs array · 1 item
[0]
the published estimate and its evidence
instruments array · 0 items
reagents array · 0 items
[1] object · 13 fields
id
obtain_source_data
order
2
name
Obtain the source data from the named repository
kind
data-preparation
state
complete
blocked_on
null
description
The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:GSE51575
outputs array · 1 item
[0]
the source data with its repository provenance
instruments array · 0 items
reagents array · 0 items
[2] object · 13 fields
id
run_analysis
order
3
name
Run the published analysis
kind
analysis
state
complete
blocked_on
null
description
Apply the paper's statistical method to the resolved series and compare the result with the published target.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:GSE51575
outputs array · 1 item
[0]
the replicated result and its comparison
instruments array · 0 items
reagents array · 0 items
materials array · 0 items
instruments array · 0 items
reagents array · 0 items
conditions object · 0 fields
gaps array · 0 items
data object · 3 fields
state
partial
assets array · 6 items
[0] object · 15 fields
id
source:pmid:34235004
role
manuscript
format
xml
media_type
application/xml
uri
https://doi.org/10.1080/2162402X.2021.1938381
sha256
sha256:40174fa7d81cf49da4ad476f7ed3028bcddfbe43fe76b59564e3056f0bbceea1
bytes
31003
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
10.1080/2162402X.2021.1938381
version
null
note
Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.
structure object · 4 fields
pmcid
PMC8216206
source
europe_pmc_fulltext
coverage
whole_body_without_references
text_hash_scope
rendered_section_body
[1] object · 15 fields
id
data:geo:GSE51575
role
raw
format
geo-series
media_type
application/vnd.ncbi.geo-series+json
uri
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE51575
sha256
null
bytes
null
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
GSE51575
version
null
note
Data are available on reasonable request. All data generated that are relevant to the results presented in this article are included in this article. Other data that were not relevant for the results presented here are available from the corresponding author Dr. Ling on reasonable request.
structure object · 15 fields
repository
GEO
access_route
GEO accession URL
access_statement_verbatim
Data are available on reasonable request. All data generated that are relevant to the results presented in this article are included in this article. Other data that were not relevant for the results presented here are available from the corresponding author Dr. Ling on reasonable request.
access_statement_kind
data_availability_statement
sample_accessions array · 52 items
[0]
GSM1248612
[1]
GSM1248613
[2]
GSM1248614
[3]
GSM1248615
[4]
GSM1248616
[5]
GSM1248617
[6]
GSM1248618
[7]
GSM1248619
[8]
GSM1248620
[9]
GSM1248621
[10]
GSM1248622
[11]
GSM1248623
[12]
GSM1248624
[13]
GSM1248625
[14]
GSM1248626
[15]
GSM1248627
[16]
GSM1248628
[17]
GSM1248629
[18]
GSM1248630
[19]
GSM1248631
[20]
GSM1248632
[21]
GSM1248633
[22]
GSM1248634
[23]
GSM1248635
[24]
GSM1248636
[25]
GSM1248637
[26]
GSM1248638
[27]
GSM1248639
[28]
GSM1248640
[29]
GSM1248641
[30]
GSM1248642
[31]
GSM1248643
[32]
GSM1248644
[33]
GSM1248645
[34]
GSM1248646
[35]
GSM1248647
[36]
GSM1248648
[37]
GSM1248649
[38]
GSM1248650
[39]
GSM1248651
[40]
GSM1248652
[41]
GSM1248653
[42]
GSM1248654
[43]
GSM1248655
[44]
GSM1248656
[45]
GSM1248657
[46]
GSM1248660
[47]
GSM1248661
[48]
GSM1248662
[49]
GSM1248663
[50]
GSM1248664
[51]
GSM1248665
sample_count
52
group_sizes
null
group_sizes_basis
null
platform
13607
taxon
Homo sapiens
title
mRNA Expression Profiling in EBV-postive Gastric Carcinoma and EBV-negative GC in comparison with their normal mucosa tissue
resolution_checked_at
2026-11-01T15:39:54Z
resolution_check
identifier_resolution_only_no_download_no_licence_read
downloaded
false
licence_read
false
[2] object · 15 fields
id
data:geo:GSE62254
role
raw
format
geo-series
media_type
application/vnd.ncbi.geo-series+json
uri
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE62254
sha256
null
bytes
null
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
GSE62254
version
null
note
Data are available on reasonable request. All data generated that are relevant to the results presented in this article are included in this article. Other data that were not relevant for the results presented here are available from the corresponding author Dr. Ling on reasonable request.
structure object · 15 fields
repository
GEO
access_route
GEO accession URL
access_statement_verbatim
Data are available on reasonable request. All data generated that are relevant to the results presented in this article are included in this article. Other data that were not relevant for the results presented here are available from the corresponding author Dr. Ling on reasonable request.
access_statement_kind
data_availability_statement
sample_accessions array · 300 items
[0]
GSM1523727
[1]
GSM1523728
[2]
GSM1523729
[3]
GSM1523744
[4]
GSM1523745
[5]
GSM1523746
[6]
GSM1523747
[7]
GSM1523748
[8]
GSM1523765
[9]
GSM1523768
[10]
GSM1523769
[11]
GSM1523770
[12]
GSM1523771
[13]
GSM1523772
[14]
GSM1523773
[15]
GSM1523774
[16]
GSM1523775
[17]
GSM1523776
[18]
GSM1523777
[19]
GSM1523778
[20]
GSM1523779
[21]
GSM1523780
[22]
GSM1523781
[23]
GSM1523782
[24]
GSM1523783
[25]
GSM1523784
[26]
GSM1523785
[27]
GSM1523786
[28]
GSM1523787
[29]
GSM1523788
[30]
GSM1523789
[31]
GSM1523790
[32]
GSM1523791
[33]
GSM1523792
[34]
GSM1523793
[35]
GSM1523794
[36]
GSM1523795
[37]
GSM1523796
[38]
GSM1523797
[39]
GSM1523798
[40]
GSM1523799
[41]
GSM1523800
[42]
GSM1523801
[43]
GSM1523802
[44]
GSM1523803
[45]
GSM1523804
[46]
GSM1523805
[47]
GSM1523806
[48]
GSM1523807
[49]
GSM1523808
[50]
GSM1523809
[51]
GSM1523810
[52]
GSM1523811
[53]
GSM1523812
[54]
GSM1523813
[55]
GSM1523814
[56]
GSM1523815
[57]
GSM1523816
[58]
GSM1523817
[59]
GSM1523818
[60]
GSM1523819
[61]
GSM1523820
[62]
GSM1523821
[63]
GSM1523822
[64]
GSM1523823
[65]
GSM1523824
[66]
GSM1523825
[67]
GSM1523826
[68]
GSM1523827
[69]
GSM1523828
[70]
GSM1523829
[71]
GSM1523830
[72]
GSM1523831
[73]
GSM1523832
[74]
GSM1523833
[75]
GSM1523834
[76]
GSM1523835
[77]
GSM1523836
[78]
GSM1523837
[79]
GSM1523838
[80]
GSM1523839
[81]
GSM1523840
[82]
GSM1523841
[83]
GSM1523842
[84]
GSM1523843
[85]
GSM1523844
[86]
GSM1523845
[87]
GSM1523846
[88]
GSM1523847
[89]
GSM1523848
[90]
GSM1523849
[91]
GSM1523850
[92]
GSM1523851
[93]
GSM1523852
[94]
GSM1523853
[95]
GSM1523854
[96]
GSM1523855
[97]
GSM1523856
[98]
GSM1523857
[99]
GSM1523858
[100]
GSM1523859
[101]
GSM1523860
[102]
GSM1523861
[103]
GSM1523862
[104]
GSM1523863
[105]
GSM1523864
[106]
GSM1523865
[107]
GSM1523866
[108]
GSM1523867
[109]
GSM1523868
[110]
GSM1523869
[111]
GSM1523870
[112]
GSM1523871
[113]
GSM1523872
[114]
GSM1523873
[115]
GSM1523874
[116]
GSM1523875
[117]
GSM1523876
[118]
GSM1523877
[119]
GSM1523878
[120]
GSM1523879
[121]
GSM1523880
[122]
GSM1523881
[123]
GSM1523882
[124]
GSM1523883
[125]
GSM1523884
[126]
GSM1523885
[127]
GSM1523886
[128]
GSM1523887
[129]
GSM1523888
[130]
GSM1523889
[131]
GSM1523890
[132]
GSM1523891
[133]
GSM1523892
[134]
GSM1523893
[135]
GSM1523894
[136]
GSM1523895
[137]
GSM1523896
[138]
GSM1523897
[139]
GSM1523898
[140]
GSM1523899
[141]
GSM1523901
[142]
GSM1523903
[143]
GSM1523904
[144]
GSM1523905
[145]
GSM1523906
[146]
GSM1523908
[147]
GSM1523909
[148]
GSM1523910
[149]
GSM1523911
[150]
GSM1523918
[151]
GSM1523919
[152]
GSM1523920
[153]
GSM1523921
[154]
GSM1523922
[155]
GSM1523923
[156]
GSM1523924
[157]
GSM1523925
[158]
GSM1523926
[159]
GSM1523927
[160]
GSM1523928
[161]
GSM1523929
[162]
GSM1523930
[163]
GSM1523931
[164]
GSM1523932
[165]
GSM1523933
[166]
GSM1523934
[167]
GSM1523935
[168]
GSM1523936
[169]
GSM1523937
[170]
GSM1523938
[171]
GSM1523939
[172]
GSM1523940
[173]
GSM1523941
[174]
GSM1523942
[175]
GSM1523943
[176]
GSM1523944
[177]
GSM1523945
[178]
GSM1523946
[179]
GSM1523947
[180]
GSM1523948
[181]
GSM1523949
[182]
GSM1523950
[183]
GSM1523951
[184]
GSM1523952
[185]
GSM1523953
[186]
GSM1523954
[187]
GSM1523955
[188]
GSM1523956
[189]
GSM1523957
[190]
GSM1523958
[191]
GSM1523959
[192]
GSM1523960
[193]
GSM1523961
[194]
GSM1523962
[195]
GSM1523963
[196]
GSM1523964
[197]
GSM1523965
[198]
GSM1523966
[199]
GSM1523967
[200]
GSM1523968
[201]
GSM1523969
[202]
GSM1523970
[203]
GSM1523971
[204]
GSM1523972
[205]
GSM1523973
[206]
GSM1523974
[207]
GSM1523975
[208]
GSM1523976
[209]
GSM1523977
[210]
GSM1523978
[211]
GSM1523979
[212]
GSM1523980
[213]
GSM1523981
[214]
GSM1523982
[215]
GSM1523983
[216]
GSM1523984
[217]
GSM1523985
[218]
GSM1523986
[219]
GSM1523987
[220]
GSM1523988
[221]
GSM1523989
[222]
GSM1523990
[223]
GSM1523991
[224]
GSM1523992
[225]
GSM1523993
[226]
GSM1523994
[227]
GSM1523995
[228]
GSM1523996
[229]
GSM1523997
[230]
GSM1523998
[231]
GSM1523999
[232]
GSM1524000
[233]
GSM1524001
[234]
GSM1524002
[235]
GSM1524003
[236]
GSM1524004
[237]
GSM1524005
[238]
GSM1524006
[239]
GSM1524007
[240]
GSM1524008
[241]
GSM1524009
[242]
GSM1524010
[243]
GSM1524011
[244]
GSM1524012
[245]
GSM1524013
[246]
GSM1524014
[247]
GSM1524015
[248]
GSM1524016
[249]
GSM1524017
[250]
GSM1524018
[251]
GSM1524019
[252]
GSM1524020
[253]
GSM1524021
[254]
GSM1524022
[255]
GSM1524023
[256]
GSM1524024
[257]
GSM1524025
[258]
GSM1524026
[259]
GSM1524027
[260]
GSM1524028
[261]
GSM1524029
[262]
GSM1524030
[263]
GSM1524031
[264]
GSM1524032
[265]
GSM1524033
[266]
GSM1524034
[267]
GSM1524035
[268]
GSM1524036
[269]
GSM1524037
[270]
GSM1524038
[271]
GSM1524039
[272]
GSM1524040
[273]
GSM1524041
[274]
GSM1524042
[275]
GSM1524043
[276]
GSM1524044
[277]
GSM1524045
[278]
GSM1524046
[279]
GSM1524047
[280]
GSM1524048
[281]
GSM1524049
[282]
GSM1524050
[283]
GSM1524051
[284]
GSM1524052
[285]
GSM1524053
[286]
GSM1524054
[287]
GSM1524055
[288]
GSM1524056
[289]
GSM1524057
[290]
GSM1524058
[291]
GSM1524059
[292]
GSM1524060
[293]
GSM1524061
[294]
GSM1524062
[295]
GSM1524068
[296]
GSM1524069
[297]
GSM1524070
[298]
GSM1524071
[299]
GSM1524072
sample_count
300
group_sizes
null
group_sizes_basis
null
platform
570
taxon
Homo sapiens
title
Molecular analysis of gastric cancer identifies discrete subtypes associated with distinct clinical characteristics and survival outcomes: the ACRG (Asian Cancer Research Group) study [gastric tumors]
resolution_checked_at
2026-11-01T15:39:55Z
resolution_check
identifier_resolution_only_no_download_no_licence_read
downloaded
false
licence_read
false
[3] object · 16 fields
id
asset:table:pmid:34235004:1
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:cd10337b89e9c994e60933b59f48734d03032f458d23d66fc15905505d18476c
bytes
1742
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[10]/table-wrap[1]#t0001
version
null
note
The effective rate of PD-1/PD-L1 inhibitors stratified by PD-L1 expression in EBVaGC
structure object · 5 fields
pmcid
PMC8216206
section_index
10
section_title
Efficacy of PD-1/PD-L1 inhibitors in EBVaGC according to PD-L1 expression
row_count
12
column_count
15
table object · 8 fields
label
Table 1.
caption
The effective rate of PD-1/PD-L1 inhibitors stratified by PD-L1 expression in EBVaGC
rows array · 12 items
[0] array · 8 items
[0]
Source
[1]
PD-L1 IHC antibody
[2]
PD-L1 evaluation
[3]
PD-1/PD-L1 inhibitors
[4]
Total number of patients
[5]
ORR (%)
[6]
Total number of patients
[7]
Number of patients (number of responders) according to PD-L1 expression
[1] array · 15 items
[0]
[1]
[2]
[3]
[4]
[5]
[6]
[7]
< 1%
[8]
≧1%
[9]
< 10%
[10]
≧10%
[11]
< 50%
[12]
≧50%
[13]
≧1%-10%
[14]
≧10%-50%
[2] array · 15 items
[0]
Tong et al., 2020
[1]
NA
[2]
TC+IC
[3]
PD-1/PD-L1 inhibitors
[4]
7
[5]
42.8
[6]
7
[7]
1 (0)
[8]
6 (3)
[9]
3 (0)
[10]
4 (3)
[11]
6 (2)
[12]
1 (1)
[13]
2 (0)
[14]
3 (2)
[3] array · 15 items
[0]
Saori et al., 2019
[1]
SP142/SP263
[2]
CPS
[3]
Nivolumab
[4]
4
[5]
25.0
[6]
4
[7]
0
[8]
4 (1)
[9]
4 (1)
[10]
0
[11]
0
[12]
0
[13]
4 (1)
[14]
0
[4] array · 15 items
[0]
Seung et al., 2018
[1]
22C3
[2]
CPS
[3]
Pembrolizumab
[4]
6
[5]
100.0
[6]
6
[7]
0
[8]
6 (6)
[9]
2 (2)
[10]
4 (4)
[11]
4 (4)
[12]
2 (2)
[13]
2 (2)
[14]
2 (2)
[5] array · 15 items
[0]
Anshuman et al., 2018
[1]
SP142
[2]
TC+IC
[3]
Avelumab
[4]
1
[5]
100.0
[6]
1
[7]
0
[8]
1 (1)
[9]
0
[10]
1 (1)
[11]
0
[12]
1 (1)
[13]
0
[14]
0
[6] array · 15 items
[0]
Jinchul et al., 2020
[1]
22C3
[2]
CPS
[3]
Nivolumab/ Pembrolizumab
[4]
4
[5]
50.0
[6]
4
[7]
1 (0)
[8]
3 (2)
[9]
NA
[10]
NA
[11]
NA
[12]
NA
[13]
NA
[14]
NA
[7] array · 15 items
[0]
F et al., 2019
[1]
SP142
[2]
TC+IC
[3]
Toripalimab
[4]
4
[5]
25.0
[6]
4
[7]
3 (0)
[8]
1 (1)
[9]
3 (0)
[10]
1 (1)
[11]
4 (1)
[12]
0
[13]
0
[14]
1 (1)
[8] array · 15 items
[0]
Yohei et al., 2020
[1]
SP142/SP263
[2]
CPS
[3]
PD-1 inhibitors
[4]
6
[5]
33.3
[6]
6
[7]
0
[8]
6 (2)
[9]
4 (1)
[10]
2 (1)
[11]
4 (1)
[12]
NA
[13]
4 (1)
[14]
NA
[9] array · 15 items
[0]
Minsuk et al., 2020
[1]
22C3
[2]
CPS
[3]
Nivolumab/ Pembrolizumab
[4]
7
[5]
42.9
[6]
7
[7]
4 (0)
[8]
3 (3)
[9]
4 (0)
[10]
NA
[11]
4 (0)
[12]
NA
[13]
NA
[14]
NA
[10] array · 15 items
[0]
Total
[1]
[2]
[3]
[4]
39
[5]
48.7
[6]
39
[7]
9 (0)
[8]
30 (19)
[9]
20 (4)
[10]
12 (10)
[11]
22 (8)
[12]
4 (4)
[13]
12 (4)
[14]
6 (5)
[11] array · 15 items
[0]
ORR (%)
[1]
[2]
[3]
[4]
[5]
[6]
[7]
0.0
[8]
63.3
[9]
20.0
[10]
83.3
[11]
36.4
[12]
100.0
[13]
33.3
[14]
83.3
locator
section[10]/table-wrap[1]#t0001
[4] object · 16 fields
id
asset:table:pmid:34235004:2
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:717196c7ef4c2ae52f261f52000e0ce32b779a5d981d2393bc8af7db16697669
bytes
2014
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[11]/table-wrap[1]#t0002
version
null
note
The clinicopathological relevance of PD-L1 expression in EBVaGC
structure object · 5 fields
pmcid
PMC8216206
section_index
11
section_title
Association of PD-L1 expression with clinicopathological characteristics in EBVaGC
row_count
47
column_count
4
table object · 8 fields
label
Table 2.
caption
The clinicopathological relevance of PD-L1 expression in EBVaGC
rows array · 47 items
[0] array · 4 items
[0]
Characteristics
[1]
PD-L1 expression*
[2]
[3]
P value
[1] array · 4 items
[0]
[1]
Negative, No. (%)
[2]
Positive, No. (%)
[3]
[2] array · 4 items
[0]
Age (years, median 57)
[1]
[2]
[3]
0.94
[3] array · 4 items
[0]
≤ 57
[1]
36 (45.0)
[2]
44 (55.0)
[3]
[4] array · 4 items
[0]
> 57
[1]
36 (45.6)
[2]
43 (54.4)
[3]
[5] array · 4 items
[0]
Sex
[1]
[2]
[3]
0.04
[6] array · 4 items
[0]
Male
[1]
68 (48.2)
[2]
73 (51.8)
[3]
[7] array · 4 items
[0]
Female
[1]
4 (22.2)
[2]
14 (77.8)
[3]
[8] array · 4 items
[0]
Primary site
[1]
[2]
[3]
0.68
[9] array · 4 items
[0]
Proximal
[1]
35 (46.7)
[2]
40 (53.3)
[3]
[10] array · 4 items
[0]
Distal
[1]
26 (47.3)
[2]
29 (52.7)
[3]
[11] array · 4 items
[0]
Stump
[1]
9 (42.9)
[2]
12 (57.1)
[3]
[12] array · 4 items
[0]
Other
[1]
2 (25.0)
[2]
6 (75.0)
[3]
[13] array · 4 items
[0]
Tumor size (cm, median 4.5)
[1]
[2]
[3]
0.05
[14] array · 4 items
[0]
≤ 4.5
[1]
32 (38.1)
[2]
52 (61.9)
[3]
[15] array · 4 items
[0]
> 4.5
[1]
40 (53.3)
[2]
35 (46.7)
[3]
[16] array · 4 items
[0]
T category**
[1]
[2]
[3]
0.14
[17] array · 4 items
[0]
T1+ T2
[1]
15 (34.9)
[2]
28 (65.1)
[3]
[18] array · 4 items
[0]
T3+ T4
[1]
52 (48.1)
[2]
56 (51.9)
[3]
[19] array · 4 items
[0]
N category**
[1]
[2]
[3]
0.001
[20] array · 4 items
[0]
N0+ N1
[1]
16 (27.6)
[2]
42 (72.4)
[3]
[21] array · 4 items
[0]
N2+ N3
[1]
50 (54.9)
[2]
41 (45.1)
[3]
[22] array · 4 items
[0]
M category
[1]
[2]
[3]
0.01
[23] array · 4 items
[0]
M0
[1]
54 (40.9)
[2]
78 (59.1)
[3]
[24] array · 4 items
[0]
M1
[1]
18 (66.7)
[2]
9 (33.0)
[3]
[25] array · 4 items
[0]
TNM classification
[1]
[2]
[3]
0.004
[26] array · 4 items
[0]
I+II
[1]
16 (29.6)
[2]
38 (70.4)
[3]
[27] array · 4 items
[0]
III+IV
[1]
56 (53.3)
[2]
49 (46.7)
[3]
[28] array · 4 items
[0]
Tumor differentiation
[1]
[2]
[3]
0.81
[29] array · 4 items
[0]
Poorly differentiated
[1]
40 (44.4)
[2]
50 (55.6)
[3]
[30] array · 4 items
[0]
Moderately differentiated
[1]
32 (46.4)
[2]
37 (53.6)
[3]
[31] array · 4 items
[0]
Lauren classification**
[1]
[2]
[3]
0.81
[32] array · 4 items
[0]
Intestinal
[1]
22 (46.8)
[2]
25 (53.2)
[3]
[33] array · 4 items
[0]
Diffuse
[1]
11 (50.0)
[2]
11 (50.0)
[3]
[34] array · 4 items
[0]
Mixed
[1]
37 (43.0)
[2]
49 (57.0)
[3]
[35] array · 4 items
[0]
Lymphoepithelioma-like gastric cancer
[1]
[2]
[3]
<0.001
[36] array · 4 items
[0]
No
[1]
38 (67.8)
[2]
18 (32.1)
[3]
[37] array · 4 items
[0]
Yes
[1]
28 (30.8)
[2]
63 (69.2)
[3]
[38] array · 4 items
[0]
Nervous invasion**
[1]
[2]
[3]
0.01
[39] array · 4 items
[0]
Negative
[1]
15 (29.4)
[2]
36 (70.6)
[3]
[40] array · 4 items
[0]
Positive
[1]
51 (51.5)
[2]
48 (48.5)
[3]
[41] array · 4 items
[0]
Venous invasion**
[1]
[2]
[3]
0.02
[42] array · 4 items
[0]
Negative
[1]
25 (34.2)
[2]
48 (65.8)
[3]
[43] array · 4 items
[0]
Positive
[1]
41 (53.2)
[2]
36 (46.8)
[3]
[44] array · 4 items
[0]
HER2 IHC score
[1]
[2]
[3]
0.01
[45] array · 4 items
[0]
0–1
[1]
54 (40.9)
[2]
78 (59.1)
[3]
[46] array · 4 items
[0]
2–3
[1]
18 (69.2)
[2]
8 (30.8)
[3]
locator
section[11]/table-wrap[1]#t0002
[5] object · 16 fields
id
asset:table:pmid:34235004:3
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:b9bb82b032951120170277a55178b1ba6f0d362df3566e810e431ca194aa33a3
bytes
1855
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[12]/table-wrap[1]#t0003
version
null
note
Univariate and multivariate Cox proportional hazards analysis for progression-free survival and overall survival in EBVaGC
structure object · 5 fields
pmcid
PMC8216206
section_index
12
section_title
Prognostic relevance of PD-L1 expression in EBVaGC
row_count
16
column_count
9
table object · 8 fields
label
Table 3.
caption
Univariate and multivariate Cox proportional hazards analysis for progression-free survival and overall survival in EBVaGC
rows array · 16 items
[0] array · 9 items
[0]
Characteristics
[1]
PFS
[2]
[3]
[4]
[5]
OS
[6]
[7]
[8]
[1] array · 9 items
[0]
[1]
Univariate analysis
[2]
[3]
Multivariate analysis
[4]
[5]
Univariate analysis
[6]
[7]
Multivariate analysis
[8]
[2] array · 9 items
[0]
[1]
HR (95% CI)
[2]
P value
[3]
HR (95% CI)
[4]
P value
[5]
HR (95% CI)
[6]
P value
[7]
HR (95% CI)
[8]
P value
[3] array · 9 items
[0]
Age (≤ 57/> 57)
[1]
0.64 (0.32–1.30)
[2]
0.22
[3]
[4]
[5]
1.16 (0.60–2.23)
[6]
0.66
[7]
[8]
[4] array · 9 items
[0]
Sex (Male/Female)
[1]
0.80 (0.28–2.28)
[2]
0.67
[3]
[4]
[5]
0.91 (0.32–2.58)
[6]
0.86
[7]
[8]
[5] array · 9 items
[0]
Tumor size (cm, ≤ 4.5/> 4.5)
[1]
2.70 (1.31–5.54)
[2]
0.01
[3]
[4]
[5]
3.88 (1.86–8.09)
[6]
<0.001
[7]
[8]
[6] array · 9 items
[0]
TMN classification (I+ II/III+IV)
[1]
27.8 (3.79–203.50)
[2]
0.001
[3]
25.42 (3.46–186.83)
[4]
0.001
[5]
25.46 (3.48–186.07)
[6]
0.001
[7]
16.62 (2.25–122.71)
[8]
0.01
[7] array · 9 items
[0]
Tumor differentiation (poorly/Moderately)
[1]
0.72 (0.36–1.46)
[2]
0.37
[3]
[4]
[5]
0.65 (0.33–1.29)
[6]
0.22
[7]
[8]
[8] array · 9 items
[0]
Lauren classification
[1]
[2]
0.97
[3]
[4]
[5]
[6]
0.26
[7]
[8]
[9] array · 9 items
[0]
Intestinal
[1]
1
[2]
Reference
[3]
[4]
[5]
1
[6]
Reference
[7]
[8]
[10] array · 9 items
[0]
Diffuse
[1]
1.15 (0.39–3.37)
[2]
0.80
[3]
[4]
[5]
2.33 (0.84–6.44)
[6]
0.10
[7]
[8]
[11] array · 9 items
[0]
Mixed
[1]
1.02 (0.47–2.23)
[2]
0.96
[3]
[4]
[5]
1.49 (0.62–3.56)
[6]
0.37
[7]
[8]
[12] array · 9 items
[0]
Nervous invasion (Negative/Positive)
[1]
2.97 (1.22–7.23)
[2]
0.02
[3]
[4]
[5]
8.71 (2.07–36.58)
[6]
0.003
[7]
[8]
[13] array · 9 items
[0]
Venous invasion (Negative/Positive)
[1]
4.46 (1.93–10.32)
[2]
<0.001
[3]
[4]
[5]
5.62 (2.15–14.68)
[6]
<0.001
[7]
[8]
[14] array · 9 items
[0]
HER2 IHC score (0–1/2-3)
[1]
1.06 (0.44–2.59)
[2]
0.89
[3]
[4]
[5]
1.83 (0.88–3.81)
[6]
0.11
[7]
[8]
[15] array · 9 items
[0]
PD-L1 expression (Negative/Positive) *
[1]
0.36 (0.18–0.73)
[2]
0.004
[3]
0.45 (0.22–0.92)
[4]
0.03
[5]
0.15 (0.07-.034)
[6]
<0.001
[7]
0.17 (0.06–0.43)
[8]
< 0.001
locator
section[12]/table-wrap[1]#t0003
gaps array · 4 items
[0]
asset:data:geo:GSE51575 not downloaded
[1]
asset:data:geo:GSE51575 licence not read
[2]
asset:data:geo:GSE62254 not downloaded
[3]
asset:data:geo:GSE62254 licence not read
analysis object · 4 fields
state
absent
methods array · 0 items
targets array · 0 items
gaps array · 2 items
[0]
method
[1]
operations
capability object · 3 fields
state
complete
requirements array · 1 item
[0] object · 6 fields
capability_id
capability:computational_analysis
label
Computational analysis platform
assay_families array · 9 items
[0]
meta_analysis
[1]
machine_learning
[2]
survival_analysis
[3]
statistical_regression
[4]
pca
[5]
molecular_docking
[6]
network_analysis
[7]
differential_expression
[8]
gwas
candidate
Automated Assays Laravel application and simulated adapters
gaps array · 0 items
readiness object · 8 fields
state
blocked
tier
R4
blocking_axis
method
blocked_on
method:not_determinable
axes object · 3 fields
method object · 5 fields
tier
R4
expressible
false
required_operations array · 0 items
missing_operations array · 0 items
basis
The reader quoted the method the paper names (not named), but the corpus's method extractor could not map it onto a DSL operation, so the method is published but not expressible.
capability object · 4 fields
tier
R1
capability_id
capability:computational_analysis
availability_state
owned
basis
The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here.
data object · 6 fields
tier
R1
reachable
true
accessions array · 2 items
[0]
GSE51575
[1]
GSE62254
resolved_accessions array · 2 items
[0]
GSE51575
[1]
GSE62254
statements array · 1 item
[0]
Data are available on reasonable request. All data generated that are relevant to the results presented in this article are included in this article. Other data that were not relevant for the results presented here are available from the corresponding author Dr. Ling on reasonable request.
basis
The paper names GSE51575, GSE62254 in Gene Expression Omnibus (GEO) and the accession resolves in the repository. No dataset was downloaded and no licence was read.
can_run object · 3 fields
dsl_operations array · 0 items
assets array · 5 items
[0]
source:pmid:34235004
[1]
data:geo:GSE51575
[2]
asset:table:pmid:34235004:1
[3]
asset:table:pmid:34235004:2
[4]
asset:table:pmid:34235004:3
steps array · 1 item
[0]
run_analysis
must_build object · 5 fields
dsl_operations array · 0 items
converters array · 0 items
readers array · 0 items
capabilities array · 0 items
data_gaps array · 1 item
[0]
data:geo:GSE51575
gaps array · 1 item
[0]
method:not_determinable
review object · 5 fields
state
partial
machine_critique object · 5 fields
kind
extraction_review
reader object · 5 fields
model
MiniMax-M3.1-Flash
provider
minimax
provider_family
minimax
read_at
2026-10-31T19:40:27Z
independence
single_reader
evidence_check object · 2 fields
method
absent
availability
verbatim
calls
3
usage object · 3 fields
prompt_tokens
26372
completion_tokens
2529
cached_tokens
776
stages array · 1 item
[0] object · 4 fields
id
extraction
state
complete
reader
MiniMax-M3.1-Flash
provider
minimax
gaps array · 3 items
[0]
review.independent_reader
[1]
review.machine_critique
[2]
review.human_critique
execution object · 5 fields
state
absent
status
not_run
mode
null
runs array · 0 items
gaps array · 1 item
[0]
execution.not_run
provenance object · 7 fields
entities array · 3 items
[0] object · 3 fields
id
pmid:34235004
type
paper
label
pmid:34235004
[1] object · 3 fields
id
source:pmid:34235004
type
manuscript
label
PMID 34235004 full text
[2] object · 3 fields
id
data:geo:GSE51575
type
dataset
label
GEO GSE51575
activities array · 3 items
[0] object · 4 fields
id
activity-reading-sci-2026-11-01
type
classification
used array · 3 items
[0] object · 3 fields
id
pmid:34235004
type
paper
label
pmid:34235004
[1] object · 3 fields
id
source:pmid:34235004
type
manuscript
label
PMID 34235004 full text
[2] object · 3 fields
id
data:geo:GSE51575
type
dataset
label
GEO GSE51575
agent
agent:corpus-assay-engine
[1] object · 4 fields
id
activity-read-34235004
type
extraction
used array · 1 item
[0]
source:pmid:34235004
agent
agent:minimax-reader
[2] object · 4 fields
id
activity-resolve-GSE51575
type
accession_resolution
used array · 1 item
[0]
data:geo:GSE51575
agent
agent:corpus-assay-engine
agents array · 2 items
[0] object · 3 fields
id
agent:corpus-assay-engine
type
software
label
Corpus assay engine
[1] object · 3 fields
id
agent:minimax-reader
type
software
label
MiniMax literature reader
source_run_id
reading-sci-2026-11-01
dsl_catalogue_fingerprint
343fb30756ba6ec3
capability_table_fingerprint
2cb3e42f047d2ecf
snapshot_id
ba34b49490d9bfaf
lineage object · 4 fields
parent_id
pmid:34235004
parent_hash
sha256:6f84698eb466191517e3db2f49b5b08ec72f490cbe8dc7486190f9cc94c7cb48
fork_of
null
gaps array · 10 items
[0]
asset:data:geo:GSE51575 licence not read
[1]
asset:data:geo:GSE51575 not downloaded
[2]
asset:data:geo:GSE62254 licence not read
[3]
asset:data:geo:GSE62254 not downloaded
[4]
execution.not_run
[5]
method
[6]
operations
[7]
review.human_critique
[8]
review.independent_reader
[9]
review.machine_critique
assays array · 1 item
[0] object · 11 fields
role
data_generation
definition_version
99e1195c7d6f
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
assay_lexicon
99e1195c7d6f
confidence
0.99
evidence array · 3 items
[0]
logic characteristics of PD-L1 expression by immunohistochemistry was analyzed in 159 patients diagnosed with
[1]
Materials and methods Patients For PD-L1 immunohistochemistry analysis in the present study, a total of 4,
[2]
EBVaGC cases were finally included for PD-L1 immunohistochemistry analysis. Supplementary Material Supplementa
order_basis
paper_text_order:546
id
assay:1
Complete file
{"sci_version": "1.2", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:34235004", "kind": "science-record", "revision": 5, "content_hash": "sha256:ec040b8e0f0a3f5f5374c14024658c9f08b9a7d1abd5d1b400285d6822505c76", "created_at": "2026-11-01T15:41:42Z", "updated_at": "2026-11-01T18:56:02Z", "generator": {"name": "corpus-assay-engine", "run_id": "reading-sci-2026-11-01"}, "paper": {"state": "complete", "title": "The clinicopathological significance and predictive value for immunotherapy of programmed death ligand-1 expression in Epstein-Barr virus-associated gastric cancer.", "doi": "10.1080/2162402X.2021.1938381", "pmid": "34235004", "authors": ["Xiao-Li Wei", "Qian-Wen Liu", "Fu-Rong Liu", "Sha-Sha Yuan", "Xiao-Fen Li", "Jia-Ning Li", "An-Li Yang", "Yi-Hong Ling"], "journal": "Oncoimmunology", "year": 2021, "abstract": "The effect of anti-programmed cell death 1 (PD-1) antibody in Epstein-Barr virus-associated gastric cancer (EBVaGC) was debatable, and no predictive biomarkers for efficacy have been reported. Public reports on anti-PD-1 antibody monotherapy-treated EBVaGC with available programmed death ligand-1 (PD-L1) expression status were summarized and analyzed. Relevance with clinicopathologic characteristics of PD-L1 expression by immunohistochemistry was analyzed in 159 patients diagnosed with EBVaGC. Relevance with genomic transcriptome and mutation profile of PD-L1 status in EBVaGC was assessed with three datasets, the cancer genome atlas (TCGA), Gene Expression Omnibus (GEO) GSE51575, and GSE62254. Based on the data from 8 reports, patients with positive PD-L1 expression (n = 30) had significantly superior objective response rate (ORR) than patients with negative PD-L1 expression (n = 9) (63.3% vs. 0%, P = .001) in EBVaGC receiving anti-PD-1 antibody monotherapy. PD-L1 positivity was associated with less aggressive clinicopathological characteristics and was an independent predictor for a longer disease-free survival (hazard ratio [HR] and 95% CI: 0.45 [0.22-0.92], P = .03) and overall survival (HR and 95% CI: 0.17 [0.06-0.43], P < .001). Analysis of public EBVaGC transcriptome and mutation datasets revealed enhanced immune-related signal pathways in PD-L1high EBVaGC and distinct mutation patterns in PD-L1low EBVaGC. PD-L1 positivity indicates a subtype of EBVaGC with 'hot' immune microenvironment, lower aggressiveness, better prognosis, and higher sensitivity to anti-PD-1 immunotherapy.", "claims": [{"id": "claim-data-access", "statement": "Data are available on reasonable request. All data generated that are relevant to the results presented in this article are included in this article. Other data that were not relevant for the results presented here are available from the corresponding author Dr. Ling on reasonable request.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:34235004", "locator": "sections[20] \"Data sharing statement\" paragraph 2", "quote": "Data are available on reasonable request. All data generated that are relevant to the results presented in this article are included in this article. Other data that were not relevant for the results presented here are available from the corresponding author Dr. Ling on reasonable request."}], "state": "complete"}], "gaps": []}, "experiment": {"state": "complete", "objective": null, "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The claim, method and evidence span published with the source article.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:34235004"], "outputs": ["the published estimate and its evidence"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data from the named repository", "kind": "data-preparation", "state": "complete", "blocked_on": null, "description": "The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:GSE51575"], "outputs": ["the source data with its repository provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the published analysis", "kind": "analysis", "state": "complete", "blocked_on": null, "description": "Apply the paper's statistical method to the resolved series and compare the result with the published target.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:GSE51575"], "outputs": ["the replicated result and its comparison"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": []}, "data": {"state": "partial", "assets": [{"id": "source:pmid:34235004", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.1080/2162402X.2021.1938381", "sha256": "sha256:40174fa7d81cf49da4ad476f7ed3028bcddfbe43fe76b59564e3056f0bbceea1", "bytes": 31003, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.1080/2162402X.2021.1938381", "version": null, "note": "Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.", "structure": {"pmcid": "PMC8216206", "source": "europe_pmc_fulltext", "coverage": "whole_body_without_references", "text_hash_scope": "rendered_section_body"}}, {"id": "data:geo:GSE51575", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE51575", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "GSE51575", "version": null, "note": "Data are available on reasonable request. All data generated that are relevant to the results presented in this article are included in this article. Other data that were not relevant for the results presented here are available from the corresponding author Dr. Ling on reasonable request.", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "Data are available on reasonable request. All data generated that are relevant to the results presented in this article are included in this article. Other data that were not relevant for the results presented here are available from the corresponding author Dr. Ling on reasonable request.", "access_statement_kind": "data_availability_statement", "sample_accessions": ["GSM1248612", "GSM1248613", "GSM1248614", "GSM1248615", "GSM1248616", "GSM1248617", "GSM1248618", "GSM1248619", "GSM1248620", "GSM1248621", "GSM1248622", "GSM1248623", "GSM1248624", "GSM1248625", "GSM1248626", "GSM1248627", "GSM1248628", "GSM1248629", "GSM1248630", "GSM1248631", "GSM1248632", "GSM1248633", "GSM1248634", "GSM1248635", "GSM1248636", "GSM1248637", "GSM1248638", "GSM1248639", "GSM1248640", "GSM1248641", "GSM1248642", "GSM1248643", "GSM1248644", "GSM1248645", "GSM1248646", "GSM1248647", "GSM1248648", "GSM1248649", "GSM1248650", "GSM1248651", "GSM1248652", "GSM1248653", "GSM1248654", "GSM1248655", "GSM1248656", "GSM1248657", "GSM1248660", "GSM1248661", "GSM1248662", "GSM1248663", "GSM1248664", "GSM1248665"], "sample_count": 52, "group_sizes": null, "group_sizes_basis": null, "platform": "13607", "taxon": "Homo sapiens", "title": "mRNA Expression Profiling in EBV-postive Gastric Carcinoma and EBV-negative GC in comparison with their normal mucosa tissue", "resolution_checked_at": "2026-11-01T15:39:54Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}, {"id": "data:geo:GSE62254", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE62254", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "GSE62254", "version": null, "note": "Data are available on reasonable request. All data generated that are relevant to the results presented in this article are included in this article. Other data that were not relevant for the results presented here are available from the corresponding author Dr. Ling on reasonable request.", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "Data are available on reasonable request. All data generated that are relevant to the results presented in this article are included in this article. Other data that were not relevant for the results presented here are available from the corresponding author Dr. Ling on reasonable request.", "access_statement_kind": "data_availability_statement", "sample_accessions": ["GSM1523727", "GSM1523728", "GSM1523729", "GSM1523744", "GSM1523745", "GSM1523746", "GSM1523747", "GSM1523748", "GSM1523765", "GSM1523768", "GSM1523769", "GSM1523770", "GSM1523771", "GSM1523772", "GSM1523773", "GSM1523774", "GSM1523775", "GSM1523776", "GSM1523777", "GSM1523778", "GSM1523779", "GSM1523780", "GSM1523781", "GSM1523782", "GSM1523783", "GSM1523784", "GSM1523785", "GSM1523786", "GSM1523787", "GSM1523788", "GSM1523789", "GSM1523790", "GSM1523791", "GSM1523792", "GSM1523793", "GSM1523794", "GSM1523795", "GSM1523796", "GSM1523797", "GSM1523798", "GSM1523799", "GSM1523800", "GSM1523801", "GSM1523802", "GSM1523803", "GSM1523804", "GSM1523805", "GSM1523806", "GSM1523807", "GSM1523808", "GSM1523809", "GSM1523810", "GSM1523811", "GSM1523812", "GSM1523813", "GSM1523814", "GSM1523815", "GSM1523816", "GSM1523817", "GSM1523818", "GSM1523819", "GSM1523820", "GSM1523821", "GSM1523822", "GSM1523823", "GSM1523824", "GSM1523825", "GSM1523826", "GSM1523827", "GSM1523828", "GSM1523829", "GSM1523830", "GSM1523831", "GSM1523832", "GSM1523833", "GSM1523834", "GSM1523835", "GSM1523836", "GSM1523837", "GSM1523838", "GSM1523839", "GSM1523840", "GSM1523841", "GSM1523842", "GSM1523843", "GSM1523844", "GSM1523845", "GSM1523846", "GSM1523847", "GSM1523848", "GSM1523849", "GSM1523850", "GSM1523851", "GSM1523852", "GSM1523853", "GSM1523854", "GSM1523855", "GSM1523856", "GSM1523857", "GSM1523858", "GSM1523859", "GSM1523860", "GSM1523861", "GSM1523862", "GSM1523863", "GSM1523864", "GSM1523865", "GSM1523866", "GSM1523867", "GSM1523868", "GSM1523869", "GSM1523870", "GSM1523871", "GSM1523872", "GSM1523873", "GSM1523874", "GSM1523875", "GSM1523876", "GSM1523877", "GSM1523878", "GSM1523879", "GSM1523880", "GSM1523881", "GSM1523882", "GSM1523883", "GSM1523884", "GSM1523885", "GSM1523886", "GSM1523887", "GSM1523888", "GSM1523889", "GSM1523890", "GSM1523891", "GSM1523892", "GSM1523893", "GSM1523894", "GSM1523895", "GSM1523896", "GSM1523897", "GSM1523898", "GSM1523899", "GSM1523901", "GSM1523903", "GSM1523904", "GSM1523905", "GSM1523906", "GSM1523908", "GSM1523909", "GSM1523910", "GSM1523911", "GSM1523918", "GSM1523919", "GSM1523920", "GSM1523921", "GSM1523922", "GSM1523923", "GSM1523924", "GSM1523925", "GSM1523926", "GSM1523927", "GSM1523928", "GSM1523929", "GSM1523930", "GSM1523931", "GSM1523932", "GSM1523933", "GSM1523934", "GSM1523935", "GSM1523936", "GSM1523937", "GSM1523938", "GSM1523939", "GSM1523940", "GSM1523941", "GSM1523942", "GSM1523943", "GSM1523944", "GSM1523945", "GSM1523946", "GSM1523947", "GSM1523948", "GSM1523949", "GSM1523950", "GSM1523951", "GSM1523952", "GSM1523953", "GSM1523954", "GSM1523955", "GSM1523956", "GSM1523957", "GSM1523958", "GSM1523959", "GSM1523960", "GSM1523961", "GSM1523962", "GSM1523963", "GSM1523964", "GSM1523965", "GSM1523966", "GSM1523967", "GSM1523968", "GSM1523969", "GSM1523970", "GSM1523971", "GSM1523972", "GSM1523973", "GSM1523974", "GSM1523975", "GSM1523976", "GSM1523977", "GSM1523978", "GSM1523979", "GSM1523980", "GSM1523981", "GSM1523982", "GSM1523983", "GSM1523984", "GSM1523985", "GSM1523986", "GSM1523987", "GSM1523988", "GSM1523989", "GSM1523990", "GSM1523991", "GSM1523992", "GSM1523993", "GSM1523994", "GSM1523995", "GSM1523996", "GSM1523997", "GSM1523998", "GSM1523999", "GSM1524000", "GSM1524001", "GSM1524002", "GSM1524003", "GSM1524004", "GSM1524005", "GSM1524006", "GSM1524007", "GSM1524008", "GSM1524009", "GSM1524010", "GSM1524011", "GSM1524012", "GSM1524013", "GSM1524014", "GSM1524015", "GSM1524016", "GSM1524017", "GSM1524018", "GSM1524019", "GSM1524020", "GSM1524021", "GSM1524022", "GSM1524023", "GSM1524024", "GSM1524025", "GSM1524026", "GSM1524027", "GSM1524028", "GSM1524029", "GSM1524030", "GSM1524031", "GSM1524032", "GSM1524033", "GSM1524034", "GSM1524035", "GSM1524036", "GSM1524037", "GSM1524038", "GSM1524039", "GSM1524040", "GSM1524041", "GSM1524042", "GSM1524043", "GSM1524044", "GSM1524045", "GSM1524046", "GSM1524047", "GSM1524048", "GSM1524049", "GSM1524050", "GSM1524051", "GSM1524052", "GSM1524053", "GSM1524054", "GSM1524055", "GSM1524056", "GSM1524057", "GSM1524058", "GSM1524059", "GSM1524060", "GSM1524061", "GSM1524062", "GSM1524068", "GSM1524069", "GSM1524070", "GSM1524071", "GSM1524072"], "sample_count": 300, "group_sizes": null, "group_sizes_basis": null, "platform": "570", "taxon": "Homo sapiens", "title": "Molecular analysis of gastric cancer identifies discrete subtypes associated with distinct clinical characteristics and survival outcomes: the ACRG (Asian Cancer Research Group) study [gastric tumors]", "resolution_checked_at": "2026-11-01T15:39:55Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}, {"id": "asset:table:pmid:34235004:1", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:cd10337b89e9c994e60933b59f48734d03032f458d23d66fc15905505d18476c", "bytes": 1742, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[10]/table-wrap[1]#t0001", "version": null, "note": "The effective rate of PD-1/PD-L1 inhibitors stratified by PD-L1 expression in EBVaGC", "structure": {"pmcid": "PMC8216206", "section_index": 10, "section_title": "Efficacy of PD-1/PD-L1 inhibitors in EBVaGC according to PD-L1 expression", "row_count": 12, "column_count": 15}, "table": {"label": "Table 1.", "caption": "The effective rate of PD-1/PD-L1 inhibitors stratified by PD-L1 expression in EBVaGC", "rows": [["Source", "PD-L1 IHC antibody", "PD-L1 evaluation", "PD-1/PD-L1 inhibitors", "Total number of patients", "ORR (%)", "Total number of patients", "Number of patients (number of responders) according to PD-L1 expression"], ["", "", "", "", "", "", "", "< 1%", "≧1%", "< 10%", "≧10%", "< 50%", "≧50%", "≧1%-10%", "≧10%-50%"], ["Tong et al., 2020", "NA", "TC+IC", "PD-1/PD-L1 inhibitors", "7", "42.8", "7", "1 (0)", "6 (3)", "3 (0)", "4 (3)", "6 (2)", "1 (1)", "2 (0)", "3 (2)"], ["Saori et al., 2019", "SP142/SP263", "CPS", "Nivolumab", "4", "25.0", "4", "0", "4 (1)", "4 (1)", "0", "0", "0", "4 (1)", "0"], ["Seung et al., 2018", "22C3", "CPS", "Pembrolizumab", "6", "100.0", "6", "0", "6 (6)", "2 (2)", "4 (4)", "4 (4)", "2 (2)", "2 (2)", "2 (2)"], ["Anshuman et al., 2018", "SP142", "TC+IC", "Avelumab", "1", "100.0", "1", "0", "1 (1)", "0", "1 (1)", "0", "1 (1)", "0", "0"], ["Jinchul et al., 2020", "22C3", "CPS", "Nivolumab/ Pembrolizumab", "4", "50.0", "4", "1 (0)", "3 (2)", "NA", "NA", "NA", "NA", "NA", "NA"], ["F et al., 2019", "SP142", "TC+IC", "Toripalimab", "4", "25.0", "4", "3 (0)", "1 (1)", "3 (0)", "1 (1)", "4 (1)", "0", "0", "1 (1)"], ["Yohei et al., 2020", "SP142/SP263", "CPS", "PD-1 inhibitors", "6", "33.3", "6", "0", "6 (2)", "4 (1)", "2 (1)", "4 (1)", "NA", "4 (1)", "NA"], ["Minsuk et al., 2020", "22C3", "CPS", "Nivolumab/ Pembrolizumab", "7", "42.9", "7", "4 (0)", "3 (3)", "4 (0)", "NA", "4 (0)", "NA", "NA", "NA"], ["Total", "", "", "", "39", "48.7", "39", "9 (0)", "30 (19)", "20 (4)", "12 (10)", "22 (8)", "4 (4)", "12 (4)", "6 (5)"], ["ORR (%)", "", "", "", "", "", "", "0.0", "63.3", "20.0", "83.3", "36.4", "100.0", "33.3", "83.3"]], "row_count": 12, "column_count": 15, "numeric_cells": 121, "header_rows": 1, "locator": "section[10]/table-wrap[1]#t0001"}}, {"id": "asset:table:pmid:34235004:2", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:717196c7ef4c2ae52f261f52000e0ce32b779a5d981d2393bc8af7db16697669", "bytes": 2014, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[11]/table-wrap[1]#t0002", "version": null, "note": "The clinicopathological relevance of PD-L1 expression in EBVaGC", "structure": {"pmcid": "PMC8216206", "section_index": 11, "section_title": "Association of PD-L1 expression with clinicopathological characteristics in EBVaGC", "row_count": 47, "column_count": 4}, "table": {"label": "Table 2.", "caption": "The clinicopathological relevance of PD-L1 expression in EBVaGC", "rows": [["Characteristics", "PD-L1 expression*", "", "P value"], ["", "Negative, No. (%)", "Positive, No. (%)", ""], ["Age (years, median 57)", "", "", "0.94"], ["≤ 57", "36 (45.0)", "44 (55.0)", ""], ["> 57", "36 (45.6)", "43 (54.4)", ""], ["Sex", "", "", "0.04"], ["Male", "68 (48.2)", "73 (51.8)", ""], ["Female", "4 (22.2)", "14 (77.8)", ""], ["Primary site", "", "", "0.68"], ["Proximal", "35 (46.7)", "40 (53.3)", ""], ["Distal", "26 (47.3)", "29 (52.7)", ""], ["Stump", "9 (42.9)", "12 (57.1)", ""], ["Other", "2 (25.0)", "6 (75.0)", ""], ["Tumor size (cm, median 4.5)", "", "", "0.05"], ["≤ 4.5", "32 (38.1)", "52 (61.9)", ""], ["> 4.5", "40 (53.3)", "35 (46.7)", ""], ["T category**", "", "", "0.14"], ["T1+ T2", "15 (34.9)", "28 (65.1)", ""], ["T3+ T4", "52 (48.1)", "56 (51.9)", ""], ["N category**", "", "", "0.001"], ["N0+ N1", "16 (27.6)", "42 (72.4)", ""], ["N2+ N3", "50 (54.9)", "41 (45.1)", ""], ["M category", "", "", "0.01"], ["M0", "54 (40.9)", "78 (59.1)", ""], ["M1", "18 (66.7)", "9 (33.0)", ""], ["TNM classification", "", "", "0.004"], ["I+II", "16 (29.6)", "38 (70.4)", ""], ["III+IV", "56 (53.3)", "49 (46.7)", ""], ["Tumor differentiation", "", "", "0.81"], ["Poorly differentiated", "40 (44.4)", "50 (55.6)", ""], ["Moderately differentiated", "32 (46.4)", "37 (53.6)", ""], ["Lauren classification**", "", "", "0.81"], ["Intestinal", "22 (46.8)", "25 (53.2)", ""], ["Diffuse", "11 (50.0)", "11 (50.0)", ""], ["Mixed", "37 (43.0)", "49 (57.0)", ""], ["Lymphoepithelioma-like gastric cancer", "", "", "<0.001"], ["No", "38 (67.8)", "18 (32.1)", ""], ["Yes", "28 (30.8)", "63 (69.2)", ""], ["Nervous invasion**", "", "", "0.01"], ["Negative", "15 (29.4)", "36 (70.6)", ""], ["Positive", "51 (51.5)", "48 (48.5)", ""], ["Venous invasion**", "", "", "0.02"], ["Negative", "25 (34.2)", "48 (65.8)", ""], ["Positive", "41 (53.2)", "36 (46.8)", ""], ["HER2 IHC score", "", "", "0.01"], ["0–1", "54 (40.9)", "78 (59.1)", ""], ["2–3", "18 (69.2)", "8 (30.8)", ""]], "row_count": 47, "column_count": 4, "numeric_cells": 84, "header_rows": 1, "locator": "section[11]/table-wrap[1]#t0002"}}, {"id": "asset:table:pmid:34235004:3", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:b9bb82b032951120170277a55178b1ba6f0d362df3566e810e431ca194aa33a3", "bytes": 1855, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[12]/table-wrap[1]#t0003", "version": null, "note": "Univariate and multivariate Cox proportional hazards analysis for progression-free survival and overall survival in EBVaGC", "structure": {"pmcid": "PMC8216206", "section_index": 12, "section_title": "Prognostic relevance of PD-L1 expression in EBVaGC", "row_count": 16, "column_count": 9}, "table": {"label": "Table 3.", "caption": "Univariate and multivariate Cox proportional hazards analysis for progression-free survival and overall survival in EBVaGC", "rows": [["Characteristics", "PFS", "", "", "", "OS", "", "", ""], ["", "Univariate analysis", "", "Multivariate analysis", "", "Univariate analysis", "", "Multivariate analysis", ""], ["", "HR (95% CI)", "P value", "HR (95% CI)", "P value", "HR (95% CI)", "P value", "HR (95% CI)", "P value"], ["Age (≤ 57/> 57)", "0.64 (0.32–1.30)", "0.22", "", "", "1.16 (0.60–2.23)", "0.66", "", ""], ["Sex (Male/Female)", "0.80 (0.28–2.28)", "0.67", "", "", "0.91 (0.32–2.58)", "0.86", "", ""], ["Tumor size (cm, ≤ 4.5/> 4.5)", "2.70 (1.31–5.54)", "0.01", "", "", "3.88 (1.86–8.09)", "<0.001", "", ""], ["TMN classification (I+ II/III+IV)", "27.8 (3.79–203.50)", "0.001", "25.42 (3.46–186.83)", "0.001", "25.46 (3.48–186.07)", "0.001", "16.62 (2.25–122.71)", "0.01"], ["Tumor differentiation (poorly/Moderately)", "0.72 (0.36–1.46)", "0.37", "", "", "0.65 (0.33–1.29)", "0.22", "", ""], ["Lauren classification", "", "0.97", "", "", "", "0.26", "", ""], ["Intestinal", "1", "Reference", "", "", "1", "Reference", "", ""], ["Diffuse", "1.15 (0.39–3.37)", "0.80", "", "", "2.33 (0.84–6.44)", "0.10", "", ""], ["Mixed", "1.02 (0.47–2.23)", "0.96", "", "", "1.49 (0.62–3.56)", "0.37", "", ""], ["Nervous invasion (Negative/Positive)", "2.97 (1.22–7.23)", "0.02", "", "", "8.71 (2.07–36.58)", "0.003", "", ""], ["Venous invasion (Negative/Positive)", "4.46 (1.93–10.32)", "<0.001", "", "", "5.62 (2.15–14.68)", "<0.001", "", ""], ["HER2 IHC score (0–1/2-3)", "1.06 (0.44–2.59)", "0.89", "", "", "1.83 (0.88–3.81)", "0.11", "", ""], ["PD-L1 expression (Negative/Positive) *", "0.36 (0.18–0.73)", "0.004", "0.45 (0.22–0.92)", "0.03", "0.15 (0.07-.034)", "<0.001", "0.17 (0.06–0.43)", "< 0.001"]], "row_count": 16, "column_count": 9, "numeric_cells": 63, "header_rows": 1, "locator": "section[12]/table-wrap[1]#t0003"}}], "gaps": ["asset:data:geo:GSE51575 not downloaded", "asset:data:geo:GSE51575 licence not read", "asset:data:geo:GSE62254 not downloaded", "asset:data:geo:GSE62254 licence not read"]}, "analysis": {"state": "absent", "methods": [], "targets": [], "gaps": ["method", "operations"]}, "capability": {"state": "complete", "requirements": [{"capability_id": "capability:computational_analysis", "label": "Computational analysis platform", "assay_families": ["meta_analysis", "machine_learning", "survival_analysis", "statistical_regression", "pca", "molecular_docking", "network_analysis", "differential_expression", "gwas"], "availability_state": "owned", "tier_unlocked": "R1", "candidate": "Automated Assays Laravel application and simulated adapters"}], "gaps": []}, "readiness": {"state": "blocked", "tier": "R4", "blocking_axis": "method", "blocked_on": "method:not_determinable", "axes": {"method": {"tier": "R4", "expressible": false, "required_operations": [], "missing_operations": [], "basis": "The reader quoted the method the paper names (not named), but the corpus's method extractor could not map it onto a DSL operation, so the method is published but not expressible."}, "capability": {"tier": "R1", "capability_id": "capability:computational_analysis", "availability_state": "owned", "basis": "The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here."}, "data": {"tier": "R1", "reachable": true, "accessions": ["GSE51575", "GSE62254"], "resolved_accessions": ["GSE51575", "GSE62254"], "statements": ["Data are available on reasonable request. All data generated that are relevant to the results presented in this article are included in this article. Other data that were not relevant for the results presented here are available from the corresponding author Dr. Ling on reasonable request."], "basis": "The paper names GSE51575, GSE62254 in Gene Expression Omnibus (GEO) and the accession resolves in the repository. No dataset was downloaded and no licence was read."}}, "can_run": {"dsl_operations": [], "assets": ["source:pmid:34235004", "data:geo:GSE51575", "asset:table:pmid:34235004:1", "asset:table:pmid:34235004:2", "asset:table:pmid:34235004:3"], "steps": ["run_analysis"]}, "must_build": {"dsl_operations": [], "converters": [], "readers": [], "capabilities": [], "data_gaps": ["data:geo:GSE51575"]}, "gaps": ["method:not_determinable"]}, "review": {"state": "partial", "machine_critique": {"kind": "extraction_review", "reader": {"model": "MiniMax-M3.1-Flash", "provider": "minimax", "provider_family": "minimax", "read_at": "2026-10-31T19:40:27Z", "independence": "single_reader"}, "evidence_check": {"method": "absent", "availability": "verbatim"}, "calls": 3, "usage": {"prompt_tokens": 26372, "completion_tokens": 2529, "cached_tokens": 776}}, "human_critique": null, "stages": [{"id": "extraction", "state": "complete", "reader": "MiniMax-M3.1-Flash", "provider": "minimax"}], "gaps": ["review.independent_reader", "review.machine_critique", "review.human_critique"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "pmid:34235004", "type": "paper", "label": "pmid:34235004"}, {"id": "source:pmid:34235004", "type": "manuscript", "label": "PMID 34235004 full text"}, {"id": "data:geo:GSE51575", "type": "dataset", "label": "GEO GSE51575"}], "activities": [{"id": "activity-reading-sci-2026-11-01", "type": "classification", "used": [{"id": "pmid:34235004", "type": "paper", "label": "pmid:34235004"}, {"id": "source:pmid:34235004", "type": "manuscript", "label": "PMID 34235004 full text"}, {"id": "data:geo:GSE51575", "type": "dataset", "label": "GEO GSE51575"}], "agent": "agent:corpus-assay-engine"}, {"id": "activity-read-34235004", "type": "extraction", "used": ["source:pmid:34235004"], "agent": "agent:minimax-reader"}, {"id": "activity-resolve-GSE51575", "type": "accession_resolution", "used": ["data:geo:GSE51575"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}, {"id": "agent:minimax-reader", "type": "software", "label": "MiniMax literature reader"}], "source_run_id": "reading-sci-2026-11-01", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "pmid:34235004", "parent_hash": "sha256:6f84698eb466191517e3db2f49b5b08ec72f490cbe8dc7486190f9cc94c7cb48", "fork_of": null, "generation": 4}, "gaps": ["asset:data:geo:GSE51575 licence not read", "asset:data:geo:GSE51575 not downloaded", "asset:data:geo:GSE62254 licence not read", "asset:data:geo:GSE62254 not downloaded", "execution.not_run", "method", "operations", "review.human_critique", "review.independent_reader", "review.machine_critique"], "assays": [{"role": "data_generation", "definition_id": "ihc", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.99, "evidence": ["logic characteristics of PD-L1 expression by immunohistochemistry was analyzed in 159 patients diagnosed with", "Materials and methods Patients For PD-L1 immunohistochemistry analysis in the present study, a total of 4,", "EBVaGC cases were finally included for PD-L1 immunohistochemistry analysis. Supplementary Material Supplementa"], "order_basis": "paper_text_order:546", "id": "assay:1"}]}